Navigating TB Eradication In Africa By Fighting Drug Resistance With Genomics

Belinda Ngongo – Director, Global Health External Affairs, Illumina Despite the advancements in tuberculosis (TB) surveillance and genomic sequencing technologies, the disease continues to be a global health crisis, constituting an excess of 10.6 million people contracting the bacterial infection in 2022. Within the same year, over 1.3 million people suffering from TB died. According […]

...

Fighting Drug Resistant TB In Africa With Genomics

Upcoming Global webinar to bring together leading experts on 22nd May to explain how genomics is changing the TB landscape. Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, this World TB Day (24th March) is urging for a rapid increase to the access and uptake of targeted next-generation sequencing (NGS) which […]

...

ASLM And Illumina Sign MOU To Increase Access To Genomics To Fight Infectious Diseases In Africa

Empowering local training in genomics and expanding access to sequencing technology The African Society for Laboratory Medicine (ASLM) and Illumina (NASDAQ: ILMN), a global leader in sequencing technology, today signed a Memorandum of Understanding at the ongoing 6th Biennial ASLM2023 conference in Cape Town, South Africa. This exciting new initiative is designed to expand the use of […]

...